Panc 02.03/Cre cells are derived from the human pancreatic cancer cell line Panc 02.03 by stably integration of a constitutive Cre recombinase stably expression construct. Panc 02.03 cells have been used in research to study pancreatic cancer biology, treatment responses, and drug development. Panc 02.03/Cre cells stably express a nuclear localized Cre recombinase.